A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

March 23, 2022

Study Completion Date

April 7, 2022

Conditions
Cognitive Impairment Associated With Schizophrenia
Interventions
DRUG

BIIB104

Administered as specified in the treatment arm

OTHER

Placebo

Administered as specified in the treatment arm

Trial Locations (60)

11516

Neurobehavioral Research, Inc., Cedarhurst

14618

Finger Lakes Clinical Research, Rochester

20877

Research Site, Gaithersburg

26655

Universitätsmedizin Göttingen, Klinik für Psychiatrie und Psychotherapie, Westerstede

28040

Hospital Universitario 12 de Octubre, Madrid

28222

Research Site, Majadahonda

30030

Research Site, Decatur

30331

Atlanta Center for Medical Research, Atlanta

30912

Augusta University, Augusta

33011

Research Site, Oviedo

33122

Premier Clinical Research Institute, Inc., Miami

33319

Research Site, Lauderhill

33613

Stedman Clinical Trials, Tampa

37005

Unidad Neurociencias CS San Juan, Salamanca

39008

Hospital Universitario Marques Valdecilla, Santander

39232

Research Site, Flowood

41013

Research Site, Seville

43210

The Ohio State University Department of Psychiatry, Columbus

44720

Research Site, North Canton

49503

Cherry Health, Grand Rapids

60169

Alexian Brothers Hospital Network, Hoffman Estates

60528

Clinic for Psychiatrie, Frankfurt am Main

60611

Research Site, Chicago

61348

Zentrum für klinische Forschung Dr. med. I. Schöll, Bad Homburg

62702

Southern Illinois University, School of Medicine, Springfield

63128

Research Site, St Louis

63141

St. Louis Clinical Trials, LC, St Louis

72712

Pillar Clinical Research, LLC, Bentonville

75080

Research Site, Richardson

78207

The University of Texas Health Science Center at San Antonio, San Antonio

90230

ProScience Research Group, Culver City

90502

Research Site, Torrance

90660

Research Site, Pico Rivera

90807

Research Site, Long Beach

91763

Catalina Research Institute, LLC, Montclair

91945

Synergy San Diego, Lemon Grove

92056

Excell Research, Oceanside

92102

CNRI - San Diego, LLC, San Diego

92103

Artemis Institute for Clinical Research, San Diego

92123

Research Site, San Diego

92845

Collaborative Neuroscience Network, LLC, Garden Grove

94901

Research Site, San Rafael

98033

Research Site, Kirkland

104051

UB Department Psychiatry, Buffalo

06519

Yale University, Department of Psychiatry, New Haven

08009

Hassman Research Institute, Berlin

04103

Dpt of Psychiatry and Psychotherapy, University of Leipzig, Leipzig

Unknown

Research Site, Anan-shi

Research Site, Ichikawa-shi

Research Site, Kashihara-shi

Research Site, Kawasaki-shi

Research Site, Kita-gun

Research Site, Kodaira-shi

Research Site, Kumagaya-shi

Research Site, Takasaki-shi

Research Site, Yokosuka-shi

08036

Hospital Clinic de Barcelona, Barcelona

OX3 7JX

Oxford Health NHS Foundation Trust, Oxford

KT16 0AE

Abraham Cowley Unit, Lyne

SE5 8AZ

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY